Table 1 Patient characteristics
Patient number: | 10 | |
Age: | ||
Range | 49-75 | |
Median | 58 | |
Sex: | ||
Male | 8 | |
Female | 2 | |
Tumor location | ||
Upper third | 1 | |
Middle third | 2 | |
Lower third | 7 | |
Histology | ||
Squamous | 3 | |
Adenocarcinoma | 7 | |
Tumor stage | ||
T3 | 3 | |
T4 | 7 | |
Nodal stage | ||
N0 | 2 | |
N1 | 5 | |
N2 | 3 | |
Treatment | ||
IMRT | 1 | |
IGRT | 9 | |
Definitive chemoradiation | 8 | |
Postoperative chemoradiation | 2 | |
Gross tumor dose (Gy) | ||
62.4 | 1 | |
65 | 1 | |
70 | 5 | |
75 | 3 | |
Boost technique | ||
Hypofractionation (2.5 Gy) | 1 | |
Hyperfractionation (1.25 Gy bid) | 4 | |
Conventional fractionation (2 Gy) | 5 | |
Follow-up (months) | ||
Range | 1-38 | |
Median | 14 | |